HAEMONETICS CORP — Director's Dealing 2015

Oct 28, 2015

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: HAEMONETICS CORP (HAE)
CIK: 0000313143
Period of Report: 2015-10-26

Reporting Person: Jesse Sandra (EVP and Chief Legal Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2015-10-26	Common Stock	S	778	$32.1291	Disposed	20096	Direct

Footnotes

F1: Sale required by Haemonetics policy for tax withholding purposes.